- Home
- AVTX vs CRON Comparison
AVTX vs CRON Comparison
Compare AVTX & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | CRON |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 956.7M | 1.1B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AVTX | CRON |
|---|---|---|
| Price | $18.82 | $2.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $40.57 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 878.8K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $27,813,137.00 | ★ $146,587,000.00 |
| Revenue This Year | N/A | $26.34 |
| Revenue Next Year | N/A | $15.53 |
| P/E Ratio | ★ N/A | $70.00 |
| Revenue Growth | ★ 2312.27 | 24.63 |
| 52 Week Low | $6.21 | $1.93 |
| 52 Week High | $24.27 | $3.43 |
Technical Indicators
Market Signals| Indicator | AVTX | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 56.23 |
| Support Level | $13.13 | $2.55 |
| Resistance Level | $19.06 | $2.81 |
| Average True Range (ATR) | 1.33 | 0.07 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 48.39 | 40.00 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.